Degradation Characteristics of a Novel PAF Receptor Antagonist, SY0916, in Aqueous Solution

SY0916 has been proven to be a potent treatment agent against rheumatoid arthritis in preclinical studies and has been shown to be safe in phase I clinical trials. However, SY0916 is unstable in water, which is frequently used in pharmaceutical development processes. The degradation behaviour and st...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Bo, Wang, Yanan, Zhang, Tingting, Yin, Wanting, Zhang, Dongfeng, Huang, Haihong, Ma, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350595/
https://www.ncbi.nlm.nih.gov/pubmed/30766739
http://dx.doi.org/10.1155/2019/8789470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350595/
https://www.ncbi.nlm.nih.gov/pubmed/30766739
http://dx.doi.org/10.1155/2019/8789470

Ejemplares similares